Metagenomics Market Growth | Global Analysis 2027

report image

Metagenomics Market to 2027 - Global Analysis and Forecasts by Product (Instruments & Software and Consumables), Application (Clinical Diagnostics, Drug Discovery Metagenomics and Others) and Geography

Publication Month: Jan 2019 | Report Code: TIPRE00002997 | No. of Pages: 139 | Category: Biotechnology | Status: Published

The metagenomics market was valued at US$ 165.8 million in 2018 and it is projected to reach US$ 314.3 million in 2027; it is expected to grow at a CAGR of 7.7% from 2019 to 2027.

Metagenomics can be defined as the study of the metagenome, which is collective genome of microorganisms. The microorganisms are collected from an environmental samples and the studies are conducted to provide information on the microbial diversity and ecology of a specific environment. The study of microorganism is conducted through the shotgun metagenomics technology/ technique which is used to extract the DNA from the environmental sample and sequence the small fragments. The metagenomic is the rising and vibrant field that has appropriated the tools used for standard genomics and applied for the study of the entire communities of microbes. This requires no need to isolate and culture the individual microbial species. The primary aim of the metagenomics is study and identify the genes and metabolic pathways present in the microbial species. The growth of the global metagenomics market is attributed to the increasing venture capital investments, advantages of metagenomics in biotechnology and industrial application of metagenomics. However, high capital cost of metagenomics is the major factor hindering the market growth.

The global metagenomics market is expected to witness substantial growth The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

Lucrative Regions for Global Metagenomics Market



Lucrative Regions for Global Metagenomics Market

Get more information on this report :


Market Insights

Advantages of Metagenomics in Biotechnology to Drive Global Metagenomics Market Growth

Metagenomic is a field that combines various important molecular technologies and enables scientists to investigate microorganisms more deeply. The technology enables to unlock the vast biotechnological potentials that are held inside the microorganisms. Metagenomics helps to identify microorganism irrespective of whether they can be cultured or not. The analysis can be done from the genomic data obtained directly from an environmental sample that provides information about the species existing and it also allow the extraction of information regarding the functionality of microbial communities in their natural habitat.

In addition, the metagenomics also holds the capabilities in the food and pharmaceutical industries. For instance, metagenomics can be useful for the identification of enzymes with desirable technological properties. This enables to relate the capable of catalyzing novel reactions which may be difficult or expensive to produce. Moreover, it enables to identify the functions under a wide range of environmental conditions encountered in food and pharmaceutical processing cycles including extreme conditions of temperature, pH, osmolarity and others.

Furthermore, the biotechnological applications from metagenomics is likely to foster by the pursuit of fundamental ecological studies and focused screens for bioprospecting. Metagenomics has contributed to the discovery of antibiotics and industrial enzymes from cultured microorganisms. For instance, the discovery of streptomycin and other bacterial antibiotics bounced from very basic studies of metagenomics. 

Therefore, owing to the advantages of the metagenomics for the application in biotechnologies are likely to boost the growth of the metagenomics market in the forecast years.

 

Product-Based Insights

In terms of product, the global metagenomics market is segmented into instruments & software and consumables. In 2018, the consumables segment held largest share of the market. Also, the same segment is estimated to register the highest CAGR during the forecast period.

Global Metagenomics Market, by Product – 2018 and 2027



Global Metagenomics Market, by Product – 2018 and 2027

Get more information on this report :


Application-Based Insights

In terms of application, the global metagenomics market is segmented into clinical diagnostic, drug discovery metagenomics and others. The clinical diagnostics segment held the largest share of the market in 2018 and the same segment is estimated to register the highest CAGR during the forecast period.

 

Strategic Insights

Report Coverage - Metagenomics Market
Report CoverageDetails
Market Size Value inUS$ 165.8 Million in 2018
Market Size Value byUS$ 314.3 Million by 2027
Growth rateCAGR of 7.7% from 2019-2027
Forecast Period2019-2027
Base Year2019
No. of Pages139
No. of Tables43
No. of Charts & Figures51
Historical data availableYes
Segments coveredProduct , Application and Geography
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

The global metagenomics market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

Global Metagenomics Market – by Product

  • Instruments & Software
  • Consumables

Global Metagenomics Market – by Application

  • Clinical Diagnostics
  • Drug Discovery
  • Others

Global Metagenomics Market – by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America and Central America (SCAM)

    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies
  • Qiagen
  • Bio-Rad Laboratories, Inc
  • Perkinelmer Inc.
  • Illumina Inc.
  • F.Hoffman-La Roche Ltd.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Bioscience of California, Inc.

Frequently Asked Questions

Metagenomics can be defined as the study of the metagenome, which is collective genome of microorganisms. The microorganisms’ samples are collected from environmental and the studies are performed to provide information on the microbial diversity and ecology of a specific environment. The study of microorganism is conducted through the shotgun technique, which is used to extract the DNA from the environmental sample and sequence the small fragments.
The growth of the global metagenomics market is attributed to the increasing venture capital investments, advantages of metagenomics in biotechnology and industrial application of metagenomics.
The most lucrative region is North America, growing at CAGR of 8%.
High capital cost of metagenomics is the major factor hindering the market growth.
The global metagenomics market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.
The List of Companies

1. Merck KGaA
2. Thermo Fisher Scientific Inc.
3. Agilent Technologies
4. Qiagen
5. Bio-Rad Laboratories, Inc.
6. Perkinelmer Inc.
7. Illumina Inc.
8. F Hoffman-La Roche Ltd.
9. Oxford Nanopore Technologies Ltd.
10. Pacific Bioscience of California, Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the metagenomics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global metagenomics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00002997
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $3000
  • $4550 $3640
  • $6550 $5240
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount